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The Scientific Activity of the Biophysics activity in 
2013 led to tremendous breakthroughs in the field of med-
ical physics and space radiation protection. The achieve-
ments are essential for the future FAIR activities, where 
the high-energy beams will open new possibilities for 
both medical and space research. It has been a very suc-
cessful year also for the technological transfer, patents, 
and awards received by group members. 
 
 
 
Figure 1: 4D-treatment plans of two lung cancer patients 
treated with C-ions. The distorted entry channel dose is a 
result of the differential motion between the target and 
other organs, such as the chest wall, during the breathing 
cycle. The sagittal cuts (bottom) illustrate the high con-
formity also in the SI main motion direction. From ref. [2] 
Medical Physics 
 
The Local Effect Model (LEM), developed by Dr. Mi-
chael Scholz, already used in treatment planning with 
heavy ions at HIT (Heidelberg) and CNAO (Italy), has 
been now extended to protons with a surprising result [3]. 
In fact, the relative biological effectiveness of protons is 
assumed to be 1.1, but our simulations show that it is 
much bigger than 1 at the end of the range, and this lead 
to a shift in the effective range of the protons (Figure 2). 
Taking into account the range shift is likely to lead to 
great improvements in proton therapy, where the market 
is much broader than in C-ion therapy (44 proton therapy 
centers are currently in operation worldwide). 
In preparation for the PRIOR facility, to be installed in 
FAIR, we produced the first-ever high-energy proton im-
age of an animal target with high-energy protons (800 
MeV) at ITEP in Moscow, Russia and then at the Los 
Alamos National Laboratory in USA (Figure 3). The 
PANTERA experiment is an APPA project developed in 
strong collaboration between the Plasma Physics and Bi-
ophysics Department at GSI.  
 
 
 
Figure 2: Predictions of the LEM model on the biological-
ly effective dose (solid orange line) along a proton SOBP 
used for therapy. The increased effectiveness of the slow 
protons results in a range shift of 2-3 mm, which could hit 
an organ at risk below the tumor.  
 
 
Figure 3: Proton radiography of a mouse obtained in 2013 
at the Los Alamos National Laboratory using 800 MeV 
proton and a setup similar to that under construction at 
FAIR (PRIOR facility). The upper image is a zoom of the 
skull. The theoretical resolution at FAIR with 4.5 GeV 
protons will be 10 µm. From ref. [4]. 
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Space Radiation 
 
GSI is the European facility selected by ESA for 
ground-based cosmic ray simulations. During 2013, we 
ran the ESA-sponsored IBER (radiobiology) and ROSSI-
NI (shielding) projects. Within IBER, we tested the possi-
bility of using human tissue slices as an alternative to 
animal studies [9]. Shielding experiments using Mars and 
Moon soil are ongoing, within the project supported by 
ESA and led by the space company Thales-Alenia Space 
(Figure 4). Results are important to estimate the depth of 
the caves/tunnels to be selected by future Moon/Mars 
explorers to build underground planetary bases without 
breaking ground for excavation.   
 
 
 
Figure 4: Martian soil under preparation for a shielding 
experiment in Cave A at GSI. The test is performed using 
1 GeV/n 56Fe-ions, whose attenuation properties have 
been shown to simulate reasonably well the attenuation of 
cosmic rays. A better simulation will be possible at FAIR 
using 10 GeV/n ions. The research is supported by ESA 
(ROSSINI contract). 
A recent research report at GSI [6] addressed an old 
question in space travel – the origin of light flashes, ob-
served by astronauts during spaceflight (first reported by 
the crew of the Apollo 11 lunar mission). Heavy charged 
particles in the cosmic rays are responsible of the light 
flash (phosphene) experienced by the astronauts, but the 
target area in the head remained unclear: some authors 
proposed the eye, while others contended that the target 
could be the optical nerve or specific areas in the brain. A 
careful analysis of the treatment plans used at GSI to treat 
patients with head-and-neck tumors show a clear correla-
tion between the dose in the retina and the perception of 
light flashes, as measured by the patient using a pushbut-
ton (Figure 6). We conclude that the phosphenes are 
caused by direct heavy ion traversals through the retina. 
 
Technological transfer 
 
RaySearch Laboratories AB (a leading Swedish com-
pany in treatment planning software) has entered into a 
license agreement with GSI regarding techniques for cal-
culating radiobiological effective dose in ion beam treat-
ments. RaySearch acquired the rights to integrate algo-
rithms and know-how from GSI related to the LEM in 
RaySearch’s RayStation® treatment planning system. The 
LEM and RaySearch’s algorithms for dose calculation 
will be built into the system’s module for carbon treat-
ment plan optimization. The first application of the sys-
tem will be at the MedAustron facility under construction 
in Wiener Neustadt (Austria). 
 
 
 
Figure 5: Example of the correlation between carbon 
beam-spot position in the head and phosphene reception 
in a patient. (A) Patient during the treatment with the fixa-
tion mask and holding the pushbutton. In this figure the 
beam is hitting the right side of the patients’ head. (B) 
Beam scanning path (beam’s eye view) for one slice of 
carbon ion irradiation. The area marked in green is corre-
lated with phosphene stimulation, based on pushbutton 
time analysis. (C) Planned physical dose distributions for 
a two-field treatment in the same patient. The beam enters 
from the right side. The color scale indicates the fraction 
of the dose to the tumor. The patient reported phoisphenes 
when the field was in the eye (green area in B).(D) Same 
as in C, but beam from the left side. No dose deposition in 
the eye, and no light flashes reported by the patient. Note 
that the optical nerves are in the field in both right and left 
irradiation. Figures from ref. [6]. 
 
The 4D treatment plan concept has been patented by C. 
Graeff and C. Bert: Erstellung eines Bestrahlungsplans 
bei bewegtem Zielvolumen ohne Bewegungskompensa-
tion“, Nr. 10 2011 056 339. The PANTERA idea for 
theranostics using high-energy protons was patented by 
H. Stöcker and M. Durante: COMBINED ION IRRADI-
ATION AND RADIOGRAPHY DEVICE - 
PCT/EP2012/071567 
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Awards 
 
Marco Durante received the 2013 IBA Prize for Ap-
plied Nuclear Science and Nuclear Methods in Medicine 
from the European Physical Society (EPS) and the 2013  
Bacq & Alexander award from the European Radiation 
Research Society (ERRS) 
Daniela Kraft received the 2013 LH Gray Young Inves-
tigator award for the European Radiation Research Annu-
al Meeting and the 2013 Christoph Schmelzer Award of 
the Verein zur Förderung der Tumortherapie mit schweren 
Ionen. 
Lisa Herr won the Philipp Siedler Award 2013 of the 
Physikalischer Verein Frankfurt. 
Thomas Friedrich got the GBS Award for Young Scien-
tists 2013, awarded by the German Society for Biological 
Radiation Research. 
Matthias Prall got the award for the best poster present-
ed at the Workshop on “Particle Radiosurgery: A new 
Frontier in Physics in Medicine”  in Obergurgl, Austria 
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